IBM-powered advanced computation used to improve light-activated chemotherapy

University of Toronto Professor, Vaughn Betz is helping Ontario-based medical device manufacturer, Theralase Technologies improve the effectiveness of light-activated cancer treatment. According to Betz, the SOSCIP collaboration’s efforts focus on using advanced computation to rapidly simulate what's going to happen when light probes are placed in certain places of the patients’ body.

Transcript

 

Feedback: Was this page useful?

Interested in doing business in Ontario?

Talk to a business consultant

Newsletter Sign Up


Form is for business purposes.

*All Fields Required




Sign up for our newsletter

Receive the latest news and updates from Invest in Ontario.


Sign up now

Back to top